TrialClinical therapeutics2008

Pharmacokinetics, pharmacodynamics, and tolerability of the dipeptidyl peptidase IV inhibitor LC15-0444 in healthy Korean men: a dose-block-randomized, double-blind, placebo-controlled, ascending single-dose, Phase I study.

Kyoung Soo Lim et al.PubMed ↗Publisher ↗

No numbers read from the abstract.